Based on the finding that plasma sTGFβR3 exhibited similar clinical associations with tumoral TGFβR3, we further confirmed their strong correlation in HCC patients (R2 = 0.112, p < 0.01) (Figure 2F). This evidence concerns the gene TGFBR3 and hepatocellular carcinoma.